MRVI - CIK 0001823239
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) reported net income of -$130.80M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$130.80M | +9.7% |
| FY 2024 | -$144.80M | -4.6% |
| FY 2023 | -$138.40M | -128.2% |
| FY 2022 | $490.70M | +4.6% |
| FY 2021 | $469.30M | +427.5% |
| FY 2020 | $88.97M | +2090.4% |
| FY 2019 | -$4.47M | - |
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) reported net income of -$130.80M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, MARAVAI LIFESCIENCES HOLDINGS, INC.'s net income declined from -$4.47M to -$130.80M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.